Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Efstathiou

Showing results (171-180 of 278) with videos related to

Pageof 28
Sort By:
Oncogene|March 8, 2018
PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53Qi Liu, Liliana Gheorghiu, Michael Drumm, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2014
Clinical-pathologic stage discrepancy in bladder cancer patients treated with radical cystectomy: results from the national cancer data basePhillip J Gray, Chun Chieh Lin, Ahmedin Jemal, et al.
European Urology Oncology|May 21, 2021
Integrating Prostate-specific Antigen Kinetics into Contemporary Predictive Nomograms of Salvage Radiotherapy After Radical ProstatectomyShauna R Campbell, Martin C Tom, Shree Agrawal, et al.
Urologic Oncology|May 19, 2023
Impact of a negative confirmatory biopsy on risk of disease progression among men on active surveillance for prostate cancerKeyan Salari, Jason Kowitz, Jeffrey Twum-Ampofo, et al.
International Journal of Radiation Oncology, Biology, Physics|March 3, 2012
Prospective preference assessment of patients' willingness to participate in a randomized controlled trial of intensity-modulated radiotherapy versus proton therapy for localized prostate cancerAnand Shah, Jason A Efstathiou, Jonathan J Paly, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 5, 2016
Collaborating to Move Research Forward: Proceedings of the 10th Annual Bladder Cancer Think TankAshish M Kamat, Piyush Agarwal, Trinity Bivalacqua, et al.
Clinical Genitourinary Cancer|September 3, 2017
Risk Factors for Disease Progression After Postprostatectomy Salvage Radiation: Long-term Results of a Single-institution ExperienceDanielle Rodin, Michael Drumm, Rebecca Clayman, et al.
Clinical Genitourinary Cancer|September 13, 2023
Does Chemo-Radiotherapy Improve Survival Outcomes vs. Radiotherapy Alone for High-Grade cT1 Urothelial Carcinoma of the Bladder?Neal Andruska, Michael R Waters, Benjamin W Fischer-Valuck, et al.
Practical Radiation Oncology|March 10, 2017
Long-term results of adjuvant versus early salvage postprostatectomy radiation: A large single-institutional experienceDaniela L Buscariollo, Michael Drumm, Andrzej Niemierko, et al.
Practical Radiation Oncology|April 24, 2025
Combination Metastasis-Targeted External Beam Radiation Therapy With <sup>177</sup>Lu-PSMA-617 in Patients With Advanced Castration-Resistant Prostate CancerSedra Mohammadi, Isabella R Pompa, Veronica Haberman, et al.
Pageof 28

Showing results (171-180 of 278) with videos related to

Sort By:
Pageof 28
Oncogene|March 8, 2018
PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53Qi Liu, Liliana Gheorghiu, Michael Drumm, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2014
Clinical-pathologic stage discrepancy in bladder cancer patients treated with radical cystectomy: results from the national cancer data basePhillip J Gray, Chun Chieh Lin, Ahmedin Jemal, et al.
European Urology Oncology|May 21, 2021
Integrating Prostate-specific Antigen Kinetics into Contemporary Predictive Nomograms of Salvage Radiotherapy After Radical ProstatectomyShauna R Campbell, Martin C Tom, Shree Agrawal, et al.
Urologic Oncology|May 19, 2023
Impact of a negative confirmatory biopsy on risk of disease progression among men on active surveillance for prostate cancerKeyan Salari, Jason Kowitz, Jeffrey Twum-Ampofo, et al.
International Journal of Radiation Oncology, Biology, Physics|March 3, 2012
Prospective preference assessment of patients' willingness to participate in a randomized controlled trial of intensity-modulated radiotherapy versus proton therapy for localized prostate cancerAnand Shah, Jason A Efstathiou, Jonathan J Paly, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 5, 2016
Collaborating to Move Research Forward: Proceedings of the 10th Annual Bladder Cancer Think TankAshish M Kamat, Piyush Agarwal, Trinity Bivalacqua, et al.
Clinical Genitourinary Cancer|September 3, 2017
Risk Factors for Disease Progression After Postprostatectomy Salvage Radiation: Long-term Results of a Single-institution ExperienceDanielle Rodin, Michael Drumm, Rebecca Clayman, et al.
Clinical Genitourinary Cancer|September 13, 2023
Does Chemo-Radiotherapy Improve Survival Outcomes vs. Radiotherapy Alone for High-Grade cT1 Urothelial Carcinoma of the Bladder?Neal Andruska, Michael R Waters, Benjamin W Fischer-Valuck, et al.
Practical Radiation Oncology|March 10, 2017
Long-term results of adjuvant versus early salvage postprostatectomy radiation: A large single-institutional experienceDaniela L Buscariollo, Michael Drumm, Andrzej Niemierko, et al.
Practical Radiation Oncology|April 24, 2025
Combination Metastasis-Targeted External Beam Radiation Therapy With <sup>177</sup>Lu-PSMA-617 in Patients With Advanced Castration-Resistant Prostate CancerSedra Mohammadi, Isabella R Pompa, Veronica Haberman, et al.
Pageof 28